nyse abbv s & p 500 component industry biopharmaceutical founded 2013 ; 3 years ago 2013 headquarters lake bluff illinois united states area served worldwide 170 countries key people richard a. gonzalez chairman & ceo revenue 22.859 billion 2015 1 operating income 7.537 billion 2015 1 net income 5.144 billion 2015 1 total assets 53.050 billion 2015 1 total equity 3.945 billion 2015 1 number of employees 28 000 2015 website abbvie.com abbvie is a pharmaceutical company that discovers develops and markets both biopharmaceuticals and small molecule drugs . it originated in 2013 as a spin off of abbott laboratories . contents 1 history 2 acquisitions 3 products 4 see also 5 references history edit on october 19 2011 abbott laboratories announced its plan to separate into two publicly traded companies . the new abbott laboratories would specialize in diversified products including medical devices diagnostic equipment and nutrition products while abbvie would operate as a research based pharmaceutical manufacturer . 2 the separation was effective january 1 2013 and abbvie was officially listed on the new york stock exchange abbv on january 2 2013 . 3 as of december 2015 the company employed in excess of 28 000 globally and provided products to individuals in more than 170 countries . 4 on september 3 2014 abbvie and infinity pharmaceuticals announced that they had entered into a global collaboration to develop and commercialize duvelisib infinity s pi3k inhibitor for the treatment of patients with cancer . on the same day abbvie and calico announced that they had entered into a r & d collaboration intended to discover develop and bring to market new therapies for patients with age related diseases including neurodegeneration and cancer . calico california life company is an alphabet inc. subsidiary led by arthur d. levinson former chairman and ceo of genentech and hal v. barron former executive vice president and chief medical officer of genentech that is focused on aging and age related diseases . 5 in october 2014 after a long negotiation abbvie stopped its efforts to acquire shire which would have been one of the largest m & a deals of that year ; abbvie had to pay a 1.6 billion breakup fee . 6 on june 3 2015 abbvie and halozyme therapeutics announced that they had entered into a global collaboration and licensing agreement to develop and commercialize products that combine abbvie s treatments and halozyme s enhanze drug delivery technology . on march 4 2015 abbvie announced its agreement to acquire the oncology firm pharmacyclics and its treatment for blood cancers ibrutinib ; astrazeneca had also been bidding to acquire pharmacyclics . 7 8 under the terms of the transaction abbvie agreed to pay 261.25 per share as a mix of cash and abbvie equity . the acquisition valued at approximately 21 billion was completed on may 26 2015 . 9 the pharmacyclics name was retained and it operates as a subsidiary of abbvie from its previous sunnyvale california headquarters . 10 according to the wall street journal as of january 2016 ibrutinib a specialty drug cost us 116 600 to 155 400 a year wholesale in the united states . in spite of discounts and medical insurance the prohibitive price causes some patients to not fill their prescriptions . 11 abbvie estimates global sales of the drug at 1 billion in 2016 and 5 billion in 2020 . 11 on february 10 2016 abbvie and cambridge massachusetts based synlogic announced a multi year r & d collaboration . synlogic is a synthetic biology company built on research from the labs of james collins and tim lu at mit . as part of the collaboration abbvie is getting worldwide rights to synlogic s probiotic based technology for treating inflammatory bowel disease and the research teams will focus on crohn s disease and ulcerative colitis . 12 in april 2016 the company partnered with the university of chicago to investigate a number of areas of oncology breast lung prostate colorectal and hematological cancers . 13 in the same month the company announced it would co commercialize argenx s preclinical immunotherapy argx 115 . argx 115 is a first in class immunotherapy targeting garp glycoprotein a repetitions predominant a membrane protein believed to enhance the immunosuppressive effects of t cells . 14 the company also announced a deal to co develop commercialize at least one of cytomx probody s conjugates against cd71 transferrin receptor 1 . 15 on 28 april 2016 the company announced it would acquire stemcentrx for up to 9.8 billion . 16 a day later the company announced an expansion of a two and a half year old cystic fibrosis deal with galapagos potentially doubling milestone payments to 600 million . 17 acquisitions edit the following is an illustration of the company s major mergers and acquisitions and historical predecessors this is not a comprehensive list abbvie inc pharmacyclics stemcentrx products edit abbvie developed adalimumab which is marketed under the trade name humira a biopharmaceutical treatment for autoimmune diseases that has exceeded 10 billion in global sales . abbvie s portfolio of medicines also includes androgel creon duodopa and duopa kaletra lupron niaspan norvir sevoflurane synagis synthroid tricor and trilipix viekira and zemplar . see also edit list of companies in the united states references edit a b c d e abbv annual report filing . morningstar.com . retrieved 1 january 2016 . abbott labs to split into 2 companies . the new york times . october 19 2011 . retrieved october 19 2011 . abbott completes separation of research based pharmaceuticals business . abbvie inc. january 2 2013 . retrieved january 2 2013 . abbvie about us . abbvie.com . retrieved 1 january 2016 . google backed calico joins abbvie in up to 1.5 b collaboration . genetic engineering & biotechnology news . september 3 2014 . retrieved june 4 2015 . gelles david 2014 . after tax inversion rules change abbvie and shire agree to terminate their deal . the new york times online october 20 ed . . zacks equity research . nisen max 2015 . astrazeneca chases abbvie cheaply . chicago business online december 17 ed . . crain s. retrieved 31 december 2015 . staff 1 april 2015 . abvie acquires oncology drug firm pharmacyclics for 21b . news industry watch . genetic engineering & biotechnology news paper . 35 5 10 . rockoff jonathan d. ; loftus peter 5 march 2015 . abbvie to buy pharmacyclics in 21 billion deal . the wall street journal . retrieved 4 june 2015 . subscription required abbvie abbv announces completion of pharmacyclics acquisition . streetinsider.com . may 26 2015 . retrieved june 5 2015 . a b walker joseph 1 january 2016 . patients struggle with high drug prices . wall street journal . retrieved 1 january 2016 . abbvie maker of world s no. 1 drug bets synthetic biology startup can raise the bar . february 10 2016 . retrieved february 10 2016 . abbvie university of chicago launch cancer research alliance . gen. abbvie to co develop argenx s cancer immunotherapy argx 115 gen news highlights gen . gen. abbvie to co commercialize cytomx s probody drug conjugates . gen. abbvie to acquire stemcentrx for up to 9.8 b . gen. galapagos abbvie expand cf collaboration to up to 600m . gen. retrieved from https en.wikipedia.org w index.php title abbvie inc. & oldid 743694297 categories 2013 establishments in illinoisbiotechnology companies of the united statescompanies based in lake county illinoiscompanies established in 2013companies listed on the new york stock exchangeorphan drug companiespharmaceutical companies of the united stateslife sciences industryhidden categories pages containing links to subscription only contentpages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages deutsch fran aisbahasa indonesiaitalianosuomisvenskataqbaylit edit links this page was last modified on 10 october 2016 at 19 16 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view